Article Sidebar

pdf
Date Published: 07/09/2024
Abstract Views: 436
Views pdf: 166
DOI: https://doi.org/10.51298/vmj.v541i3.10918
Issue
Vol. 541 No. 3 (2024)
Section
Các bài báo
How to Cite
Nguyễn, H. P., & Phan, T. N. B. (2024). COMPARISON OF DIAGNOSTIC VALUE OF ANA-ELISA AND ANA IMMUNOFLUORESCENCE IN CONNECTIVE TISSUE DISEASES. Vietnam Medical Journal, 541(3). https://doi.org/10.51298/vmj.v541i3.10918

COMPARISON OF DIAGNOSTIC VALUE OF ANA-ELISA AND ANA IMMUNOFLUORESCENCE IN CONNECTIVE TISSUE DISEASES

Hoàng Phương Nguyễn, Thị Ngọc Bích Phan

Main Article Content

Abstract

Objective: Comparison of the diagnostic value of antinuclear antibody (ANA) testing using ELISA and indirect immunofluorescence (IIF) techniques in autoimmune diseases. Materials and methods: The study was conducted from October to December 2022. Sera from 59 patients with autoimmune diseases and 34 healthy controls were tested for ANA using ELISA (ANA-ELISA) and indirect immunofluorescence (ANA-IIF) techniques. Results: Among the 62 serum samples with ANA-IIF (+), the most common staining pattern was speckle (53.23%). The sensitivities of ANA-IIF and ANA-ELISA for autoimmune diseases were 97.22% and 91.76%, respectively, and for SLE were 88.14% and 86.44%, respectively. The specificity of ANA-ELISA for autoimmune diseases is 88.24%, higher than ANA-IIF at 70.59%. The false positive rate of ANA-IIF in the control group was 17.65% compared to 0% of ANA-ELISA. Conclusions: ANA-ELISA has lower sensitivity but higher specificity than ANA-IIF in screening and diagnosing autoimmune diseases.

Article Details

Keywords

antinuclear antibody, ELISA, indirect immunofluorescence.

References

1. Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol. 2020 Dec;16(12):715-726.
2. Neveen A. Kamel, Ashraf A. Hassaballa, Yomna M. Hasan. Detection of antinuclear antibody in autoimmune connectivetissue diseases: a comparison between immunofluorescence and solid-phase assay. Al-Azhar Assiut Med J 16:223–228
3. Alsaed OS, Alamlih LI, Al-Radideh O, Chandra P, Alemadi S, Al-Allaf AW. Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases. Sci Rep. 2021 Apr 15;11(1):8229.
4. El-Chennawi FA, Mosaad YM, Habib HM, El-Degheidi T. Comparative study of antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay in lupus patients. Immunol Invest. 2009;38(8):839-50.
5. Tayde A, Agrawal C, A. T. Deshmukh. Comparison of immunofluorescence assay (IF) with ELISA in detection of antinuclear antibodies. Indian Journal of Pathology and Oncology, 2018;5(3):418-420.